----
Current ValuationThe current P/E ratio is -27.22, below the reasonable range, cheaper than 88.04% of the time in the past 5 years, and the industry ranks 48/52, the industry Median 6.69.
-27.22xP/E
HK$4.83Stock price
HK$-0.18Earnings per share
-27.22xP/E
Stock priceHK$4.83Earnings per shareHK$-0.18
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- -14.99x
- Typical range
- -24.34x–-11.26x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 6.69x
09182736
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 6.69x
0x20x40x60x80x100x
| Name/Symbol | |||
|---|---|---|---|
06887HKSUNSHINE PHARMA | -67.82x | -- | HK$22.25B |
02630HKVIGONVITA-B | -36.58x | -- | HK$12.84B |
00570HKTRAD CHI MED | -5.09x | 223.71% | HK$5.92B |
09637HKALEBUND-B | -7.10x | 48.51% | HK$5.75B |
02575HKXUANZHUBIO-B | -17.37x | -- | HK$4.20B |
01477HKOCUMENSION-B | -27.22x | 52.83% | HK$3.93B |
01349HKFUDANZHANGJIANG | -20.20x | -- | HK$2.43B |
02552HKHUA MEDICINE-B | -18.99x | 104.78% | HK$2.36B |
02652HKCF PHARMTECH | -279.87x | -- | HK$2.19B |
06622HKZHAOKE OPHTH-B | -4.48x | -- | HK$1.11B |
01652HKFUSEN PHARM | -275.15x | -- | HK$735.60M |
01011HKNT PHARMA | -10.02x | -- | HK$317.99M |
01643HKMODERN CHI MED | -5.00x | -- | HK$241.20M |
00575HKREGENT PACIFIC | -15.74x | -- | HK$240.75M |
00455HKTIANDA PHARMA | -2.77x | -- | HK$191.35M |
08329HKNEP INTERLONG | -3.09x | -- | HK$187.94M |
01312HKKONTA CHINA | -0.71x | -- | HK$150.89M |
00858HKEXTRAWELL PHAR | -0.13x | -- | HK$124.70M |
01498HKPURAPHARM | -4.46x | -- | HK$123.26M |
01889HKSANAI HEALTH GP | -1.22x | -- | HK$27.37M |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
